Brain Wealthy
    What's Hot

    Gardasil Injection Lawsuit Claims HPV Vaccine Caused Neurological and Autonomic Dysfunction

    February 2, 2023

    Research project applies a global lens to student mental health

    February 2, 2023

    FSU psychologist receives $3.7 million grant to combat anxiety in seniors with Alzheimer’s and cognitive impairment

    February 2, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Brain Wealthy
    • Home
    • Anxiety

      FSU psychologist receives $3.7 million grant to combat anxiety in seniors with Alzheimer’s and cognitive impairment

      February 2, 2023

      How to Reduce Anxiety in Stressful Situations

      February 2, 2023

      The cat in boots The last wish taught me about anxiety

      February 2, 2023

      Inseparable cat trio with ‘separation anxiety brothers’ find new home

      February 2, 2023

      Declining sales of COVID-19 drugs. Pharmacies were warned against mailing abortion pills.Depression, pollution leading to anxiety

      February 2, 2023
    • Emotion

      Ontario paramedic emotional during last radio call

      February 2, 2023

      A Pianist Faces Death and Recorded Music of Unspeakable Emotions

      February 2, 2023

      Return of home post linking Gichaara to ancestors is emotional for north coast nation

      February 2, 2023

      Mother of two sues New York school district for ‘mental distress’ caused by mask enforcement

      February 2, 2023

      Emotional (mis)perceptions: Is the EU missing the mark?

      February 2, 2023
    • Neurology

      Gardasil Injection Lawsuit Claims HPV Vaccine Caused Neurological and Autonomic Dysfunction

      February 2, 2023

      REGENXBIO’s Duchenne Therapy RGX-202 Clinical Trial Begins Patient Recruitment

      February 2, 2023

      Aducanumab for the treatment of Alzheimer’s disease

      February 2, 2023

      Potential for Effective Comparative Studies and Treatment Approval in Epilepsy Care: Anup Patel, MD

      February 2, 2023

      Head injury does not predict memory impairment in NFL retirees, UT Southwestern study shows: Newsroom

      February 2, 2023
    • Sleep

      Get a better night’s sleep with better pillows from The Pillow Bar in Dallas

      February 2, 2023

      Is it okay to sleep with a necklace on?

      February 2, 2023

      Does tart cherry juice improve sleep?

      February 2, 2023

      Social Jet Lag, Sleep Chronotypes, and Why We Gotta Close Our Eyes and Embrace It

      February 2, 2023

      Too much sex and too little sleep can kill these endangered marsupials.smart news

      February 2, 2023
    • Brain Research

      spark!Talk – video available online

      February 2, 2023

      Studies have found that obesity-related neurodegeneration mimics Alzheimer’s disease.newsroom

      February 2, 2023

      The Brain Observatory: New Museum to Participate in Museum Month

      February 1, 2023

      who wants to live forever

      February 1, 2023

      UK company makes surprise forays

      February 1, 2023
    • Brain Wealth
      1. Mental Health
      2. View All

      Research project applies a global lens to student mental health

      February 2, 2023

      DC Metro shooting suspect undergoes mental health evaluation after rampage

      February 2, 2023

      Gov. Ho-Chol unveils details of $1 billion plan to overhaul New York State’s mental health care continuum

      February 2, 2023

      Boston, we have a problem: data on mental health and practice come in

      February 2, 2023

      Research project applies a global lens to student mental health

      February 2, 2023

      DC Metro shooting suspect undergoes mental health evaluation after rampage

      February 2, 2023

      Gov. Ho-Chol unveils details of $1 billion plan to overhaul New York State’s mental health care continuum

      February 2, 2023

      Boston, we have a problem: data on mental health and practice come in

      February 2, 2023
    Brain Wealthy
    Home»Neurology»Nuclear Medicine Market Size to be USD 19.47 Billion by 2028
    Neurology

    Nuclear Medicine Market Size to be USD 19.47 Billion by 2028

    brainwealthy_vws1exBy brainwealthy_vws1exJanuary 18, 2023No Comments6 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Nuclear Medicine Market to be worth US$19.47 billion by 2028 | Report by Fortune Business Insights

    Pune, India, January 18, 2023 (GLOBE NEWSWIRE) — Global


    nuclear medicine market

    The size was valued at US$5.04 billion in 2020 and US$5.57 billion in 2021. The market is expected to reach USD 19.47 by 2028, at a CAGR of 19.6% during the forecast period. The market growth is mainly due to the increasing incidence of chronic diseases. Additionally, technological advancements that allow radiopharmaceuticals to be used to analyze and treat cancerous tumors will help the market grow.

    Fortune Business Insights™ Share this information in the report titled “Nuclear Medicine Market Forecast, 2023-2028.”

    industrial development

    Bracco Diagnostics Inc. has announced a collaboration with CardioNavix, LLC to enhance patient access to cardiac PET imaging. This new program, the Bracco Mobile Isotope Service, will enable more patient care sites to offer cardiac PET imaging.

    Request a sample copy of the report:

    https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

    Report scope and segmentation

    report coverage

    detail

    Forecast period

    2021-2028

    Forecast period 2020-2027 CAGR

    19.6%

    2028 value projection

    US$19.47 billion

    base year

    2020

    Market size in 2020

    US$5.04 billion

    historical data

    2017-2019

    page number

    169

    driving factor

    Technological advances in nuclear imaging modalities boosting the market

    One of the fundamental aspects of the growth of the nuclear medicine market is the growing awareness of the potential impact of primary and timely diagnosis and positive agitation in long-term disability management and treatment. The development of nuclear imaging techniques, especially PET/PET-CT, has helped expand the application of this modality beyond oncology to cardiology, neurology, and the identification of infectious diseases.

    important point

    • Market players focusing on various strategies, such as new product launches, are expected to increase revenue over the next year.

    • Development of new therapeutic products for treatment of various medical conditions stimulating market growth.

    • North America is expected to generate USD 2.57 billion in 2020 and continue to dominate the market during the forecast period.

    • Increasing prevalence of various cancers and other chronic diseases is expected to boost the growth of the North American market during the forecast period.

    View full report details:

    https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

    segmentation

    Based on type, the market is segmented into diagnostic and therapeutic radiopharmaceuticals. The diagnostic radiopharmaceutical segment is estimated to hold a dominant share of the global market in 2020.

    In terms of application, the market is segmented into neurology, cardiology, oncology, and others.

    By end-user, the market is segmented into hospitals and clinics, diagnostic centers, and others.

    Geographically, the market is branched into North America, Europe, Asia Pacific, and the rest of the world.

    Regional Insight

    North America Leads, Supported by Increased Use of Therapeutic Radiopharmaceuticals

    North America is expected to generate a revenue of US$2.57 billion in 2020 and maintain its dominance during the forecast period. Rapid adoption of pooled operational nuclear imaging technology with increasing utilization of technically sound and proficient therapeutic radiopharmaceuticals across the region is expected to boost the market growth.

    Europe is estimated to hold the second highest nuclear medicine market share due to advanced radiopharmaceutical adoption and current product launches by prominent players.

    Asia Pacific is projected to expand at a significant CAGR during the forecast period.

    competitive environment

    Partnerships initiated by key players to drive market growth

    Dominant players of the market continuously endorse resourceful strategies to enhance their brand value and drive the growth of the global market for their products while facing unimaginable obstacles. One such effective strategy is to acquire a competitive firm and enhance the interests of both firms involved.

    Access full report –

    nuclear medicine

    market:

    https://www.fortunebusinessinsights.com/checkout-page/101812

    List of major players covered in the report

    • Lantheus Medical Imaging, Inc. (USA)

    • Cardinal Health (United States)

    • Norgine BV (Netherlands)

    • Nordion (Canada) Inc. (Canada)

    • Bayer AG (Germany)

    • Curium (France)

    • Advanced Accelerator Applications (Novartis AG) (France)

    • Bracco Diagnostic Inc. (USA)

    • Jubilant Pharmova Limited (India)

    • GE Healthcare (General Electric Company) (U.S.)

    Main points of the table of contents:

    • prologue

      • Market range

      • market segmentation

      • research method

      • definitions and assumptions

    • executive summary

    • market dynamics

      • market driver

      • market constraints

      • market opportunity

      • Market trend

    • key insight

      • Installed Base of PET/PET-CT Scanners – Select Countries, 2015 and 2019

      • Gamma Camera Installed Base – Selected Countries, 2019

      • PET/PET-CT treatment volumes – selected countries, 2019

      • Redemption scenarios – for major countries

      • New product launch

      • major industry developments

      • Pipeline analysis

      • Market Impact of COVID-19

    • Global Nuclear Medicine Market Analysis, Insights and Forecasts, 2017-2028

      • Main Findings/Summary

      • Market Analysis, Insights & Forecasts – By Type

        • diagnose

          • PET Radiopharmaceutical

            • FDG-PET/18F

            • 68Ga

            • 68Cu

            • 11C

            • others

          • SPECT radiopharmaceuticals

            • Technetium-99m

            • Iodine-123

            • Xenon-133

            • Thallium-201

            • others

        • Therapeutics

      • Market Analysis, Insights & Forecasts – By Application

        • neurology

        • cardiology

        • oncology

        • others

      • Market Analysis, Insights & Forecasts – By End User

        • hospitals and clinics

        • diagnostic center

        • others

      • Market Analysis, Insights & Forecasts – By Region

        • North America

        • Europe

        • Asia Pacific

        • rest of the world

    • North America Nuclear Medicine Market Analysis, Insights and Forecasts, 2017-2028

      • Main Findings/Summary

      • Market Analysis, Insights & Forecasts – By Type

        • diagnose

          • PET Radiopharmaceutical

            • FDG-PET/18F

            • 68Ga

            • 68Cu

            • 11C

            • others

          • SPECT radiopharmaceuticals

            • Technetium-99m

            • Iodine-123

            • Xenon-133

            • Thallium-201

            • others

        • Therapeutics

      • Market Analysis, Insights & Forecasts – By Application

        • neurology

        • cardiology

        • Oncology

        • others

      • Market Analysis, Insights & Forecasts – By End User

        • hospitals and clinics

        • diagnostic center

        • others

      • Market Analysis, Insights & Forecasts – By Country

    • European Nuclear Medicine Market Analysis, Insights and Forecasts, 2017-2028

      • Main Findings/Summary

      • Market Analysis, Insights & Forecasts – By Type

        • diagnose

          • PET Radiopharmaceutical

            • FDG-PET/18F

            • 68Ga

            • 68Cu

            • 11C

            • others

          • SPECT radiopharmaceuticals

            • Technetium-99m

            • Iodine-123

            • Xenon-133

            • Thallium-201

            • others

        • Therapeutics

    TOC Continuing…

    Questions? Ask the Experts:

    https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

    Related Links:

    Radiation dose management market

    Scale, Share, Revenue Forecast, Opportunity

    Radiation therapy market

    Overview, industry share, forecast

    Digital radiography market

    Scale, Share, Opportunity, Analysis

    about us:

    Fortune Business Insights™ provides professional enterprise analytics and accurate data to help organizations of all sizes make timely decisions. We tailor innovative solutions for our clients to help them address their unique business challenges. Our goal is to provide clients with holistic market information and provide a detailed overview of the markets in which they operate. Our report contains a unique mix of concrete insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market research interspersed with relevant data.

    inquiry:

    Fortune Business Insights™ Pvt.

    USA: +1 424 253 0390

    UK: +44 2071 939123

    Asia Pacific: +91 744 740 1245

    Email:

    sales@fortunebusinessinsights.com



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleJames Martin broke down in tears after ‘TV Dad’ gave him an emotional health update.Television and Radio | Showbiz and Television
    Next Article Journal of the Neurological Sciences Issue 443 is now available
    brainwealthy_vws1ex
    • Website

    Related Posts

    Gardasil Injection Lawsuit Claims HPV Vaccine Caused Neurological and Autonomic Dysfunction

    February 2, 2023

    REGENXBIO’s Duchenne Therapy RGX-202 Clinical Trial Begins Patient Recruitment

    February 2, 2023

    Aducanumab for the treatment of Alzheimer’s disease

    February 2, 2023
    Add A Comment

    Leave A Reply Cancel Reply

    Top Posts

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    This website provides information about Brain and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Facebook Twitter Instagram Pinterest YouTube
    Top Insights

    Top UK Stocks to Watch: Capita Shares Rise as it Unveils

    January 15, 2021
    8.5

    Digital Euro Might Suck Away 8% of Banks’ Deposits

    January 12, 2021

    Oil Gains on OPEC Outlook That U.S. Growth Will Slow

    January 11, 2021
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2023 brainwealthy. Designed by brainwealthy.
    • Home
    • Contact us
    • DMCA
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.